Dr. Reichert, Executive Director of The Antibody Society, is an internationally-recognized expert in the development of antibody and peptide therapeutics.
She is Founder and Managing Director of Reichert Biotechnology Consulting LLC, a biopharmaceutical business intelligence research firm, and Founder and Editor-in-Chief of mAbs, a peer-reviewed, PubMed-indexed biomedical journal that focuses on topics relevant to antibody research and development.
Dr. Reichert has published extensively on development trends for antibody therapeutics, and she has presented her research results as an invited speaker at conferences held worldwide.
She is co-editor of the Handbook of Therapeutic Antibodies, and serves on the editorial boards of several biomedical journals.
Dr. Reichert received her PhD in Chemistry from the University of Pennsylvania and did her post-doctoral training at Harvard Medical School.